Therapies for chronic renal failure
US6861404B1 · kind B1 · utility
45Cited by
0References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 6, 1997 |
| Grant date | Mar 1, 2005 |
| Priority date | — |
| Expiry date | May 6, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P13/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods for the treatment, and pharmaceuticals for use in the treatment, of mammalian subjects in, or at risk of chronic renal failure, or at risk of a need for renal replacement therapy. The methods involve the administration of certain proteins of, or based upon, the osteogenic protein/bone morphogenetic protein (OP/BMP) family within the TGF-βsuperfamily of proteins.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.